Article Text

other Versions

Download PDFPDF
p-ANCA in Autoimmune Liver Disorders Recognize Human Beta-Tubulin Isotype 5 and Cross-react with Microbial Protein FtsZ
  1. Birgit Terjung1,*,
  2. Jennifer Soehne1,
  3. Berthold Lechtenberg1,
  4. Judith Gottwein1,
  5. Marit Muennich1,
  6. Volker Herzog2,
  7. Michael Maehler3,
  8. Tilman Sauerbruch1,
  9. Ulrich Spengler1
  1. 1 Department of Internal Medicine, University of Bonn, Germany;
  2. 2 Institute of Cell Biology, University of Bonn, Germany;
  3. 3 Biomedical Diagnostics, Hannover, Germany
  1. Correspondence to: Birgit Terjung, Department of Internal Medicine, University of Bonn, Sigmund-Freud-Strasse 25, Bonn, 53105, Germany; birgit.terjung{at}


Objective: Autoimmune hepatitis and primary sclerosing cholangitis are chronic inflammatory disorders of unknown aetiology, frequently associated with the presence of perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) directed against an unknown antigen of myeloid cells.

Methods & Results: Here, we report that p-ANCA in autoimmune liver disorders react with beta-tubulin isotype 5 (TBB-5) as autoantigen as well as with its evolutionary bacterial precursor protein FtsZ. Both proteins were confirmed as antigens of p-ANCA in autoimmune liver disorders by demonstrating reactivity of ANCA-positive sera with recombinant TBB-5 (72-88%) and FtsZ (64-82%) on immunoblots and antigen-specific abrogation of ANCA immunofluorescence when sera had been pre-absorbed with tubulin and FtsZ. Using sera from interleukin-10 deficient mice (Il10-/-), an animal model of inflammatory bowel disease, we also demonstrated that antibodies against TBB-5 are generated in response to intestinal microorganisms. However, unlike autoimmune liver disorders, human antibodies to FtsZ in the absence of TBB-5 antibodies were also a frequent finding in non-autoimmune liver diseases (up to 95%). Reactivity to TBB-5 without presence of FtsZ antibodies was found in very few cases (< 1%) in autoimmune liver disorders.

Conclusions: Thus, p-ANCA in autoimmune liver diseases are directed against human TBB-5 cross-reacting with the bacterial protein FtsZ, probably reflecting an abnormal immune response to intestinal microorganisms in susceptible, possibly genetically pre-disposed individuals.

Statistics from

Supplementary materials

  • Web only app


Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles